ARTICLE | Clinical News
Geniom Real Time Analyzer: Postmarketing study data
October 26, 2009 7:00 AM UTC
GRTA identified 165 miRNAs that were significantly up- or down-regulated in patients with relapsing-remitting MS (RRMS) vs. healthy controls. The most significantly deregulated biomarker, has-miR-145,...